HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POORPROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHENADJUSTED WITH COMORBIDITIES


SEVİNDİK Ö. G., Güç Z., KAHRAMAN S., Medini Ş., Katgı A., ACAR C., ...More

13th International Symposium on Myelodyspastic Syndromes /, 29 April - 02 May 2015, vol.39, pp.123

  • Publication Type: Conference Paper / Summary Text
  • Volume: 39
  • Page Numbers: pp.123
  • Dokuz Eylül University Affiliated: Yes